Omega-3 polyunsaturated fatty acids prevent obesity by improving tricarboxylic acid cycle homeostasis

J Nutr Biochem. 2021 Feb:88:108503. doi: 10.1016/j.jnutbio.2020.108503. Epub 2020 Sep 19.

Abstract

The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on preventing obesity are well known; however, the underlying mechanism by which n-3 PUFAs influence tricarboxylic acid (TCA) cycle under obesity remains unclear. We randomly divided male C57BL/6 mice into 5 groups (n=10) and fed for 12 weeks as follows: mice fed a normal diet (Con, 10% kcal); mice fed a high-fat diet (HFD, lard, 60% kcal); and mice fed a high-fat diet (60% kcal) substituting half the lard with safflower oil (SO), safflower oil and fish oil (SF) and fish oil (FO), respectively. Then we treated HepG2 cells with palmitic acid and DHA for 24 h. We found that body weight in FO group was significantly lower than it in HFD and SO groups. N-3 PUFAs reduced the transcription and translation of TCA cycle enzymes, including IDH1, IDH2, SDHA, FH and MDH2, to enhance mitochondrial function in vivo and vitro. DHA significantly inhibited protein expression of the mTORC1 signaling pathway, increased p-AKT protein expression to alleviate insulin resistance and improved mitochondrial oxygen consumption rate and glycolysis ability in HepG2 cells. In addition, the expressions of IDH2 and SDHB were reduced by rapamycin. N-3 PUFAs could prevent obesity by improving TCA cycle homeostasis and mTORC1 signaling pathway may be upstream.

Keywords: Insulin resistance; Mitochondrial function; N-3 PUFAs; Obesity; TCA cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Citric Acid Cycle / drug effects*
  • Diet, High-Fat / adverse effects
  • Docosahexaenoic Acids / pharmacology
  • Fatty Acids, Omega-3 / pharmacology*
  • Fish Oils / pharmacology
  • Glycolysis / drug effects
  • Hep G2 Cells
  • Homeostasis / drug effects
  • Humans
  • Insulin Resistance
  • Male
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria / metabolism
  • Obesity / metabolism
  • Obesity / prevention & control*
  • Oxygen Consumption / drug effects
  • Palmitic Acid / pharmacology
  • Safflower Oil / pharmacology

Substances

  • Fatty Acids, Omega-3
  • Fish Oils
  • Docosahexaenoic Acids
  • Palmitic Acid
  • Safflower Oil
  • Mechanistic Target of Rapamycin Complex 1